Abstract:Background and Purpose Allosterism is a regulatory mechanism for GPCRs that can be attained by ligand‐binding or protein–protein interactions with another GPCR. We have studied the influence of the dimer interface on the allosteric properties of the A2A receptor and CB2 receptor heteromer. Experimental Approach We have evaluated cAMP production, phosphorylation of signal‐regulated kinases (pERK1/2), label‐free dynamic mass redistribution, β‐arrestin 2 recruitment and bimolecular fluorescence complementation assays in the absence and presence of synthetic peptides that disrupt the formation of the heteromer. Molecular dynamic simulations provided converging evidence that the heteromeric interface influences the allosteric properties of the A2AR–CB2R heteromer. Key Results Apo A2AR blocks agonist‐induced signalling of CB2R. The disruptive peptides, with the amino acid sequence of transmembrane (TM) 6 of A2AR or CB2R, facilitate CB2R activation, suggesting that A2AR allosterically prevents the outward movement of TM 6 of CB2R for G protein binding. Significantly, binding of the selective antagonist SCH 58261 to A2AR also facilitated agonist‐induced activation of CB2R. Conclusions and Implications It is proposed that the A2AR–CB2R heteromer contains distinct dimerization interfaces that govern its functional properties. The molecular interface between protomers of the A2AR–CB2R heteromer interconverted from TM 6 for apo or agonist‐bound A2AR, blocking CB2R activation, to mainly the TM 1/7 interface for antagonist‐bound A2AR, facilitating the independent opening of intracellular cavities for G protein binding. These novel results shed light on a different type of allosteric mechanism and extend the repertoire of GPCR heteromer signalling.

Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization

GPCR heteromers: An overview of their classification, function and physiological relevance

G Protein-Coupled Receptor Dimerization—What Next?

Membrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR Function

GPCR oligomers in pharmacology and signaling

Structural Basis of Orientated Asymmetry in a Mglu Heterodimer

Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.

Unique Pharmacology of mGluR homo- and heterodimers

A key interfacial residue identified with in-cell structure characterization of a class A GPCR dimer

Structural features of the G-protein/GPCR interactions

Stabilised D R G-protein coupled receptor oligomers identify multi-state β-arrestin complexes

Structure and dynamics determine G protein coupling specificity at a class A GPCR

Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling

Allosterism in the adenosine A2A and cannabinoid CB2 heteromer

Functional relevance of neurotransmitter receptor heteromers in the central nervous system

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Synthesis and evaluation of homodimeric GnRHR antagonists having a rigid bis-propargylated benzene core

Structures of human mGlu2 and mGlu7 homo- and heterodimers

Molecular Mechanisms of GPCR Signaling: A Structural Perspective

Single-molecule FRET imaging of GPCR dimers in living cells

Structural basis for GPCR-independent activation of heterotrimeric Gi proteins